We serve Chemical Name:1-[(3,4-dimethylphenyl)methyl]piperazine CAS:212393-09-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![1-[(3,4-dimethylphenyl)methyl]piperazine](https://a.dearchem.com/CAS2/212393-09-4.png)
Chemical Name:1-[(3,4-dimethylphenyl)methyl]piperazine
CAS.NO:212393-09-4
Synonyms:or0073
Molecular Formula:C13H20N2
Molecular Weight:204.31100
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:15.27000
Exact Mass:204.16300
LogP:1.97530
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like or0073 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,or0073 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,or0073 Use and application,or0073 technical grade,usp/ep/jp grade.
Related News: Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. 1-[(3,4-dimethylphenyl)methyl]piperazine manufacturer Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. 1-[(3,4-dimethylphenyl)methyl]piperazine supplier Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. 1-[(3,4-dimethylphenyl)methyl]piperazine vendor Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 1-[(3,4-dimethylphenyl)methyl]piperazine factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.
